Capitalizing on Prescribing Pattern Variation to Compare Medications for Type 2 Diabetes

Our findings suggest increased risk of major adverse events associated with SUs as a second-line agent. Quasi-experimental IV methods may be an important alternative to lengthening clinical trials to assess long-term outcomes.